Company / Capital Expenditures
IRONWOOD PHARMACEUTICALS INC Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$34.0K
FY2025
5-year range
$34.0K / $1.8M
FY2021-FY2025
Trend
-75.0%
vs FY2024
Sector context
#182 of 194
Health Care
What the data says
Among 194 Health Care companies, IRONWOOD PHARMACEUTICALS INC is in the bottom 6% for capital expenditures. Capital Expenditures has declined for 3 consecutive years, from $2M in FY2022 to $34,000 in FY2025.
Based on SEC 10-K filings.
$34,000 in FY2025 with a 5-year CAGR of -37.3%.
Declined from $273,000 to $34,000 over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -73.6%
- 5-Year CAGR
- -37.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 194This company $34.0K Sector average $117.5M
▼
-100.0% below sector average
Key checks
Key Insights
- IRONWOOD PHARMACEUTICALS INC's capital expenditures has declined for 3 consecutive years.
- 5-year CAGR of -37.3%, indicating a declining trend.
- In FY2025, capital expenditures decreased 75.0% year-over-year.
- Ranks #182 out of 194 companies in the Health Care sector.
Company context
Key Data Points
- Altman Z-Score -2.17 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.0K | -75.0% |
| FY2024 | $136.0K | -50.2% |
| FY2023 | $273.0K | -85.2% |
| FY2022 | $1.8M | +595.1% |
| FY2021 | $265.0K | -24.5% |
| FY2020 | $351.0K | -95.1% |
| FY2019 | $7.2M | +70.9% |
| FY2018 | $4.2M | +50.1% |
| FY2017 | $2.8M | -33.4% |
| FY2016 | $4.2M | +3.9% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026